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Background: The incremental prognostic value of myocardial perfusion imaging (MP) during contrast stress-echocardiography (cSE) has been 
demonstrated, but whether this applies to patients with known coronary artery disease (CAD) who are at high risk for hard cardiac events (all-cause 
death and nonfatal myocardial infarction) remains to be determined.
methods: We analyzed the outcome of 754 patients with known CAD referred for Dipyridamole (n=483) or Dobutamine (n=271) cSE in two 
echo labs (Parma, Italy and Omaha, USA) between 2005 and 2011, with a mean follow-up time of 39±24 months. MP and wall motion (WM) were 
assessed at rest and stress using real time perfusion imaging with either intravenous Sonovue or Definity contrast agents.
results: Patients without either a fixed or reversible MP defect had a 3 year mortality of 1.7% and a hard cardiac event rate of 3.1%, while patients 
without rest or reversible WM abnormalities had a mortality rate of 3.7% and hard event rate of 6.0% (p<0.001 compared to MP). C-index was 
higher (p=0.015) when MP analysis was added to clinically predictive variables and WM data; net reclassification index confirmed (p<0.01) better 
risk stratification by MP.
conclusions: Patients with known CAD but no fixed or reversible MP defects during cSE fared significantly better than patients without either rest 
or reversible WM abnormalities, whose cardiac hard event rate and all-cause mortality was doubled.
